Mannatech (NASDAQ:MTEX) Stock Crosses Below Two Hundred Day Moving Average – Should You Sell?

Shares of Mannatech, Incorporated (NASDAQ:MTEX) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $8.96 and traded as low as $8.11. Mannatech shares last traded at $8.30, with a volume of 6,412 shares changing hands.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Mannatech in a research note on Monday. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Mannatech currently has an average rating of “Sell”.

Mannatech Price Performance

The company has a debt-to-equity ratio of 0.48, a current ratio of 1.13 and a quick ratio of 0.56. The stock has a market cap of $15.77 million, a P/E ratio of -9.65 and a beta of 0.79. The company’s 50 day simple moving average is $9.19 and its 200 day simple moving average is $8.96.

Mannatech (NASDAQ:MTEX) last announced its quarterly earnings results on Wednesday, November 12th. The company reported $1.01 earnings per share for the quarter. Mannatech had a negative net margin of 1.50% and a negative return on equity of 22.75%. The company had revenue of $29.16 million for the quarter.

Mannatech Company Profile

Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.

The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.